Yongjiang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongjiang Ma has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Yugu Li
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
5 shared publications Daotong Li
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
3 shared publications- Kaizhao Zhang
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
3 shared publications Yaqiong Ye
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
3 shared publicationsYugu Li
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
3 shared publicationsHaoran Ma
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
2 shared publications
Latest Publications
- Open Access
- 8 July 2025
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 71 (3) , 771-787
Advancements in ocular surface reconstruction by mesenchymal stem cells and immunomodulatory mechanism
Current clinical treatment for limbal stem cell deficiency (LSCD) relies mainly on allogeneic transplantation, but the lack of donors and postoperative rejection has resulted in many patients facing treatment difficulties. Mesenchymal stem cells (MSCs), a class of adult stem cells with self-renewal and multidirectional differentiation potential, are widely distributed in various tissues, including dental pulp, adipose tissue, umbilical cord, bone marrow, and hair follicles. Due to their autologous availability, the ability to differentiate into corneal epithelial-like cells, and unique properties of mediating matrix reconstruction and immune regulation via exosomes, this approach presents significant potential in treating corneal diseases. These characteristics establish MSCs as a crucial approach to tackling the combined issues of donor scarcity and immune rejection in patients with bilateral LSCD, providing an innovative alternative for the functional and structural restoration of the ocular surface. This review systematically examines the roles of recent advancements in research on MSCs derived from umbilical cord, dental pulp, adipose tissue, bone marrow, hair follicles, and induced pluripotent stem cells (iPSCs) for corneal reconstruction. It analyzes and compares the strengths and weaknesses of different MSCs in treating corneal injuries. Various research groups have systematically addressed challenges such as the scarcity of cell sources, insufficient mechanical support, and the risk of immune rejection through three dimensions: cell function reconstruction, biomaterials combination, and technological pathway upgrades. However, the long-term survival and functioning of transplanted cells in the host’s immune system remain significant obstacles in the application of stem cells. Therefore, the immunomodulatory properties of MSCs are crucial to promote their in vivo differentiation and participation in ocular surface repair. This article focuses on elucidating how MSCs regulate the expansion of Tregs through CD80 target binding and non-target-mediated cell contact, as well as the secretion of soluble factors such as TSG-6, HGF, IL-10, and TGF-β, and the delivery of regulatory molecules like miR-22 and miR-150-5p via extracellular vehicles (EVs). These mechanisms aim to restore the balance between Th17 and Tregs, providing an in-depth analysis of the immune mechanisms involved in MSC-mediated ocular surface reconstruction. This review discusses the challenges encountered in the clinical translation of MSC-based therapies for corneal diseases. These challenges include functional exhaustion resulting from chronic inflammatory microenvironments, variability in efficacy due to source heterogeneity, inadequate differentiation efficiency, and the potential for postoperative scarring. Current research is focusing on innovative solutions based on engineering technologies to mitigate these bottlenecks. The research includes the development of engineered EV delivery systems featuring targeted modifications, the loading of functional molecules, and the adjustment of surface charge to enhance binding to corneal cells and improve enrichment in inflammatory regions; the preparation of microneedle arrays for precise and sustained exosome delivery; and the directed differentiation of corneal stromal cells in combination with gelatin-based hydrogel scaffolds to construct biomimetic corneal stroma and reduce fibrosis. Recent research findings suggest potential future directions for the development of MSCs. Based on this, the article proposes a new treatment plan for LSCD utilizing 3D technology and engineering combined with MSCs, aiming to overcome the current limitations of MSC therapy. This work aims to disseminate recent research on ocular surface reconstruction utilizing MSCs and MSC-EVs, facilitating comprehension for non-professionals and encouraging discussion with leading researchers. Through ongoing innovation and collaboration between academia and industry, we expect the development of more efficient and clinically appropriate MSC-based treatment strategies.
- 8 July 2025
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 71 (3) , 771-787
Open AccessAdvancements in ocular surface reconstruction by mesenchymal stem cells and immunomodulatory mechanism
Current clinical treatment for limbal stem cell deficiency (LSCD) relies mainly on allogeneic transplantation, but the lack of donors and postoperative rejection has resulted in many patients facing treatment difficulties. Mesenchymal stem cells (MSCs), a class of adult stem cells with self-renewal and multidirectional differentiation potential, are widely distributed in various tissues, including dental pulp, adipose tissue, umbilical cord, bone marrow, and hair follicles. Due to their autologous availability, the ability to differentiate into corneal epithelial-like cells, and unique properties of mediating matrix reconstruction and immune regulation via exosomes, this approach presents significant potential in treating corneal diseases. These characteristics establish MSCs as a crucial approach to tackling the combined issues of donor scarcity and immune rejection in patients with bilateral LSCD, providing an innovative alternative for the functional and structural restoration of the ocular surface. This review systematically examines the roles of recent advancements in research on MSCs derived from umbilical cord, dental pulp, adipose tissue, bone marrow, hair follicles, and induced pluripotent stem cells (iPSCs) for corneal reconstruction. It analyzes and compares the strengths and weaknesses of different MSCs in treating corneal injuries. Various research groups have systematically addressed challenges such as the scarcity of cell sources, insufficient mechanical support, and the risk of immune rejection through three dimensions: cell function reconstruction, biomaterials combination, and technological pathway upgrades. However, the long-term survival and functioning of transplanted cells in the host’s immune system remain significant obstacles in the application of stem cells. Therefore, the immunomodulatory properties of MSCs are crucial to promote their in vivo differentiation and participation in ocular surface repair. This article focuses on elucidating how MSCs regulate the expansion of Tregs through CD80 target binding and non-target-mediated cell contact, as well as the secretion of soluble factors such as TSG-6, HGF, IL-10, and TGF-β, and the delivery of regulatory molecules like miR-22 and miR-150-5p via extracellular vehicles (EVs). These mechanisms aim to restore the balance between Th17 and Tregs, providing an in-depth analysis of the immune mechanisms involved in MSC-mediated ocular surface reconstruction. This review discusses the challenges encountered in the clinical translation of MSC-based therapies for corneal diseases. These challenges include functional exhaustion resulting from chronic inflammatory microenvironments, variability in efficacy due to source heterogeneity, inadequate differentiation efficiency, and the potential for postoperative scarring. Current research is focusing on innovative solutions based on engineering technologies to mitigate these bottlenecks. The research includes the development of engineered EV delivery systems featuring targeted modifications, the loading of functional molecules, and the adjustment of surface charge to enhance binding to corneal cells and improve enrichment in inflammatory regions; the preparation of microneedle arrays for precise and sustained exosome delivery; and the directed differentiation of corneal stromal cells in combination with gelatin-based hydrogel scaffolds to construct biomimetic corneal stroma and reduce fibrosis. Recent research findings suggest potential future directions for the development of MSCs. Based on this, the article proposes a new treatment plan for LSCD utilizing 3D technology and engineering combined with MSCs, aiming to overcome the current limitations of MSC therapy. This work aims to disseminate recent research on ocular surface reconstruction utilizing MSCs and MSC-EVs, facilitating comprehension for non-professionals and encouraging discussion with leading researchers. Through ongoing innovation and collaboration between academia and industry, we expect the development of more efficient and clinically appropriate MSC-based treatment strategies.
- Open Access
- 18 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12494
Molecular Mechanism of Mouse Uterine Smooth Muscle Regulation on Embryo Implantation
Myometrium plays critical roles in multiple processes such as embryo spacing through peristalsis during mouse implantation, indicating vital roles of smooth muscle in the successful establishment and quality of implantation. Actin, a key element of cytoskeleton structure, plays an important role in the movement and contraction of smooth muscle cells (SMCs). However, the function of peri-implantation uterine smooth muscle and the regulation mechanism of muscle tension are still unclear. This study focused on the molecular mechanism of actin assembly regulation on implantation in smooth muscle. Phalloidin is a highly selective bicyclic peptide used for staining actin filaments (also known as F-actin). Phalloidin staining showed that F-actin gradually weakened in the CD-1 mouse myometrium from day 1 to day 4 of early pregnancy. More than 3 mice were studied for each group. Jasplakinolide (Jasp) used to inhibit F-actin depolymerization promotes F-actin polymerization in SMCs during implantation window and consequently compromises embryo implantation quality. Transcriptome analysis following Jasp treatment in mouse uterine SMCs reveals significant molecular changes associated with actin assembly. Tagln is involved in the regulation of the cell cytoskeleton and promotes the polymerization of G-actin to F-actin. Our results show that Tagln expression is gradually reduced in mouse uterine myometrium from day 1 to 4 of pregnancy. Furthermore, progesterone inhibits the expression of Tagln through the progesterone receptor. Using siRNA to knock down Tagln in day 3 SMCs, we found that phalloidin staining is decreased, which confirms the critical role of Tagln in F-actin polymerization. In conclusion, our data suggested that decreases in actin assembly in uterine smooth muscle during early pregnancy is critical to optimal embryo implantation. Tagln, a key molecule involved in actin assembly, regulates embryo implantation by controlling F-actin aggregation before implantation, suggesting moderate uterine contractility is conducive to embryo implantation. This study provides new insights into how the mouse uterus increases its flexibility to accommodate implanting embryos in the early stage of pregnancy.
- 18 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12494
Open AccessMolecular Mechanism of Mouse Uterine Smooth Muscle Regulation on Embryo Implantation
Myometrium plays critical roles in multiple processes such as embryo spacing through peristalsis during mouse implantation, indicating vital roles of smooth muscle in the successful establishment and quality of implantation. Actin, a key element of cytoskeleton structure, plays an important role in the movement and contraction of smooth muscle cells (SMCs). However, the function of peri-implantation uterine smooth muscle and the regulation mechanism of muscle tension are still unclear. This study focused on the molecular mechanism of actin assembly regulation on implantation in smooth muscle. Phalloidin is a highly selective bicyclic peptide used for staining actin filaments (also known as F-actin). Phalloidin staining showed that F-actin gradually weakened in the CD-1 mouse myometrium from day 1 to day 4 of early pregnancy. More than 3 mice were studied for each group. Jasplakinolide (Jasp) used to inhibit F-actin depolymerization promotes F-actin polymerization in SMCs during implantation window and consequently compromises embryo implantation quality. Transcriptome analysis following Jasp treatment in mouse uterine SMCs reveals significant molecular changes associated with actin assembly. Tagln is involved in the regulation of the cell cytoskeleton and promotes the polymerization of G-actin to F-actin. Our results show that Tagln expression is gradually reduced in mouse uterine myometrium from day 1 to 4 of pregnancy. Furthermore, progesterone inhibits the expression of Tagln through the progesterone receptor. Using siRNA to knock down Tagln in day 3 SMCs, we found that phalloidin staining is decreased, which confirms the critical role of Tagln in F-actin polymerization. In conclusion, our data suggested that decreases in actin assembly in uterine smooth muscle during early pregnancy is critical to optimal embryo implantation. Tagln, a key molecule involved in actin assembly, regulates embryo implantation by controlling F-actin aggregation before implantation, suggesting moderate uterine contractility is conducive to embryo implantation. This study provides new insights into how the mouse uterus increases its flexibility to accommodate implanting embryos in the early stage of pregnancy.
- Open Access
miR-152-3p Represses the Proliferation of the Thymic Epithelial Cells by Targeting Smad2
MicroRNAs (miRNAs) control the proliferation of thymic epithelial cells (TECs) for thymic involution. Previous studies have shown that expression levels of miR-152-3p were significantly increased in the thymus and TECs during the involution of the mouse thymus. However, the possible function and potential molecular mechanism of miR-152-3p remains unclear. This study identified that the overexpression of miR-152-3p can inhibit, while the inhibition of miR-152-3p can promote, the proliferation of murine medullary thymic epithelial cell line 1 (MTEC1) cells. Moreover, miR-152-3p expression was quantitatively analyzed to negatively regulate Smad2, and the Smad2 gene was found to be a direct target of miR-152-3p, using the luciferase reporter assay. Importantly, silencing Smad2 was found to block the G1 phase of cells and inhibit the cell cycle, which was consistent with the overexpression of miR-152-3p. Furthermore, co-transfection studies of siRNA–Smad2 (siSmad2) and the miR-152-3p mimic further established that miR-152-3p inhibited the proliferation of MTEC1 cells by targeting Smad2 and reducing the expression of Smad2. Taken together, this study proved miR-152-3p to be an important molecule that regulates the proliferation of TECs and therefore provides a new reference for delaying thymus involution and thymus regeneration.
Open AccessmiR-152-3p Represses the Proliferation of the Thymic Epithelial Cells by Targeting Smad2
MicroRNAs (miRNAs) control the proliferation of thymic epithelial cells (TECs) for thymic involution. Previous studies have shown that expression levels of miR-152-3p were significantly increased in the thymus and TECs during the involution of the mouse thymus. However, the possible function and potential molecular mechanism of miR-152-3p remains unclear. This study identified that the overexpression of miR-152-3p can inhibit, while the inhibition of miR-152-3p can promote, the proliferation of murine medullary thymic epithelial cell line 1 (MTEC1) cells. Moreover, miR-152-3p expression was quantitatively analyzed to negatively regulate Smad2, and the Smad2 gene was found to be a direct target of miR-152-3p, using the luciferase reporter assay. Importantly, silencing Smad2 was found to block the G1 phase of cells and inhibit the cell cycle, which was consistent with the overexpression of miR-152-3p. Furthermore, co-transfection studies of siRNA–Smad2 (siSmad2) and the miR-152-3p mimic further established that miR-152-3p inhibited the proliferation of MTEC1 cells by targeting Smad2 and reducing the expression of Smad2. Taken together, this study proved miR-152-3p to be an important molecule that regulates the proliferation of TECs and therefore provides a new reference for delaying thymus involution and thymus regeneration.
- 30 October 2021
- Published by Wiley in Journal of Applied Toxicology
- Vol. 42 (4) , 660-670
Proteomic analysis of zearalenone toxicity on mouse thymic epithelial cells
Zearalenone (ZEA) is one of the most major food contaminants in cereal crops worldwide, risking health of both livestock and humans. This study aimed to assess the cytotoxicity and the underlying mechanism of ZEA on thymic epithelial cells. By using proteomics analysis, we identified 596 differentially expressed proteins in MTEC1 cells upon zearalenone exposure, of which 245 were upregulated and 351 were downregulated. Gene ontology (GO) analysis suggested that differentially expressed proteins were participated in protein synthesis, oxidative phosphorylation, and ATP binding. KEGG pathway enrichment analysis showed that differentially expressed proteins were mainly related to mitochndrial metabolism, such as citrate cycle (TCA cycle) and oxidative phosphorylation. We demonstrated that ZEA treatment was able to increase the intracellular reactive oxygen species (ROS) level, to decrease ΔΨm, ATP level, and the copy number of mtDNA, leading to necrotic cell death. Moreover, we showed that ZEA treatment inhibited cell proliferation and induced G2/M phase arrest by downregulation of proliferation-associated proteins ERK, p-ERK, CDK1, and p-CHK1. Taken together, we found that the toxicity of ZEA on thymic epithelial cells is mainly caused by the inhibition of mitochondrial dysfunction and cell proliferation. Our study might open new avenues for treatment strategies.
- 30 October 2021
- Published by Wiley in Journal of Applied Toxicology
- Vol. 42 (4) , 660-670
Proteomic analysis of zearalenone toxicity on mouse thymic epithelial cells
Zearalenone (ZEA) is one of the most major food contaminants in cereal crops worldwide, risking health of both livestock and humans. This study aimed to assess the cytotoxicity and the underlying mechanism of ZEA on thymic epithelial cells. By using proteomics analysis, we identified 596 differentially expressed proteins in MTEC1 cells upon zearalenone exposure, of which 245 were upregulated and 351 were downregulated. Gene ontology (GO) analysis suggested that differentially expressed proteins were participated in protein synthesis, oxidative phosphorylation, and ATP binding. KEGG pathway enrichment analysis showed that differentially expressed proteins were mainly related to mitochndrial metabolism, such as citrate cycle (TCA cycle) and oxidative phosphorylation. We demonstrated that ZEA treatment was able to increase the intracellular reactive oxygen species (ROS) level, to decrease ΔΨm, ATP level, and the copy number of mtDNA, leading to necrotic cell death. Moreover, we showed that ZEA treatment inhibited cell proliferation and induced G2/M phase arrest by downregulation of proliferation-associated proteins ERK, p-ERK, CDK1, and p-CHK1. Taken together, we found that the toxicity of ZEA on thymic epithelial cells is mainly caused by the inhibition of mitochondrial dysfunction and cell proliferation. Our study might open new avenues for treatment strategies.
- Open Access
- 1 January 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 207, 111511
Resveratrol alleviates zea-induced decidualization disturbance in human endometrial stromal cells
- 1 January 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 207, 111511
Open AccessResveratrol alleviates zea-induced decidualization disturbance in human endometrial stromal cells
- 1 June 2020
- Published by Elsevier in Molecular Immunology
- Vol. 122, 173-185
miR-205-5p inhibits thymic epithelial cell proliferation via FA2H-TFAP2A feedback regulation in age-associated thymus involution
- 1 June 2020
- Published by Elsevier in Molecular Immunology
- Vol. 122, 173-185
miR-205-5p inhibits thymic epithelial cell proliferation via FA2H-TFAP2A feedback regulation in age-associated thymus involution
- Open Access
Effects of Castration on miRNA, lncRNA, and mRNA Profiles in Mice Thymus
Thymic degeneration and regeneration are regulated by estrogen and androgen. Recent studies have found that long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are involved in organ development. In this study, RNA sequencing (RNA-seq) results showed that ovariectomy significantly affected 333 lncRNAs, 51 miRNAs, and 144 mRNAs levels (p < 0.05 and |log2fold change| > 1), and orchiectomy significantly affected 165 lncRNAs, 165 miRNAs, and 208 mRNA levels in the thymus. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that differentially expressed genes (DEGs) were closely related to cell development and immunity. Next, we constructed two lncRNA–miRNA–mRNA networks using Cytoscape based on the targeting relationship between differentially expressed miRNAs (DEMs) and DEGs and differentially expressed lncRNAs (DELs) analyzed by TargetScan and miRanda. Besides, we screened DEGs that were significantly enriched in GO and in ceRNA networks to verify their expression in thymocytes and thymic epithelial cells (TECs). In addition, we analyzed the promoter sequences of DEGs, and identified 25 causal transcription factors. Finally, we constructed transcription factor-miRNA-joint target gene networks. In conclusion, this study reveals the effects of estrogen and androgen on the expression of miRNAs, lncRNAs, and mRNAs in mice thymus, providing new insights into the regulation of thymic development by gonadal hormones and non-coding RNAs.
Open AccessEffects of Castration on miRNA, lncRNA, and mRNA Profiles in Mice Thymus
Thymic degeneration and regeneration are regulated by estrogen and androgen. Recent studies have found that long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are involved in organ development. In this study, RNA sequencing (RNA-seq) results showed that ovariectomy significantly affected 333 lncRNAs, 51 miRNAs, and 144 mRNAs levels (p < 0.05 and |log2fold change| > 1), and orchiectomy significantly affected 165 lncRNAs, 165 miRNAs, and 208 mRNA levels in the thymus. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that differentially expressed genes (DEGs) were closely related to cell development and immunity. Next, we constructed two lncRNA–miRNA–mRNA networks using Cytoscape based on the targeting relationship between differentially expressed miRNAs (DEMs) and DEGs and differentially expressed lncRNAs (DELs) analyzed by TargetScan and miRanda. Besides, we screened DEGs that were significantly enriched in GO and in ceRNA networks to verify their expression in thymocytes and thymic epithelial cells (TECs). In addition, we analyzed the promoter sequences of DEGs, and identified 25 causal transcription factors. Finally, we constructed transcription factor-miRNA-joint target gene networks. In conclusion, this study reveals the effects of estrogen and androgen on the expression of miRNAs, lncRNAs, and mRNAs in mice thymus, providing new insights into the regulation of thymic development by gonadal hormones and non-coding RNAs.
- 1 May 2018
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 153, 135-141
Transcriptional profiling analysis of Zearalenone-induced inhibition proliferation on mouse thymic epithelial cell line 1
- 1 May 2018
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 153, 135-141
Transcriptional profiling analysis of Zearalenone-induced inhibition proliferation on mouse thymic epithelial cell line 1
- 1 August 2015
- Vol. 50 (8) , 966-72
[Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
Ribavirin is a broad-spectrum antiviral agent and glycyrrhizin has activities of anti-inflammation, immunoregulation and anti-viral infections. To enhance antiviral efficacy and weaken side-effects of ribavirin, antiviral effects of the combination of glycyrrhizin and ribavirin were studied in the present study. Firstly, a mouse model of viral pneumonia was established by inoculation of influenza H1N1 virus. Protective effects of glycyrrhizin and ribavirin used alone or in combination against H1N1 virus infection in mice were evaluated based on the survival rate, lung index and virus titer in lungs of mice. Results showed that the combination of glycyrrhizin and ribavirin significantly inhibited the lung consolidation with a 36% inhibition ratio on the lung swell of infected mice. The combination of the two drugs exhibited synergetic effects on survival of infected mice. The combination of 50 mg · kg(-1) · d(-1) glycyrrhizin and 40 mg · kg(-1) · d(-1) ribavirin resulted a 100% protection for infected mice with a synergetic value of 36, which was significantly higher than the control group and each drug alone. This combination also resulted a significant drop of lung virus titer (P < 0.01), as well as inhibition on the production of proinflammatory cytokines IL-6 (P < 0.01), TNF-α (P < 0.01) and IL-1β (P < 0.05) induced by virus infection compared to the control. The treatment of ribavirin plus glycyrrhizin was more effective in influenza A infection in mice than either compound used alone, which suggested a potential clinical value of the combination of the two agents.
- 1 August 2015
- Vol. 50 (8) , 966-72
[Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
Ribavirin is a broad-spectrum antiviral agent and glycyrrhizin has activities of anti-inflammation, immunoregulation and anti-viral infections. To enhance antiviral efficacy and weaken side-effects of ribavirin, antiviral effects of the combination of glycyrrhizin and ribavirin were studied in the present study. Firstly, a mouse model of viral pneumonia was established by inoculation of influenza H1N1 virus. Protective effects of glycyrrhizin and ribavirin used alone or in combination against H1N1 virus infection in mice were evaluated based on the survival rate, lung index and virus titer in lungs of mice. Results showed that the combination of glycyrrhizin and ribavirin significantly inhibited the lung consolidation with a 36% inhibition ratio on the lung swell of infected mice. The combination of the two drugs exhibited synergetic effects on survival of infected mice. The combination of 50 mg · kg(-1) · d(-1) glycyrrhizin and 40 mg · kg(-1) · d(-1) ribavirin resulted a 100% protection for infected mice with a synergetic value of 36, which was significantly higher than the control group and each drug alone. This combination also resulted a significant drop of lung virus titer (P < 0.01), as well as inhibition on the production of proinflammatory cytokines IL-6 (P < 0.01), TNF-α (P < 0.01) and IL-1β (P < 0.05) induced by virus infection compared to the control. The treatment of ribavirin plus glycyrrhizin was more effective in influenza A infection in mice than either compound used alone, which suggested a potential clinical value of the combination of the two agents.
- Open Access
- 30 December 2014
- Published by Springer Nature in Virology Journal
- Vol. 11 (1) , 229
Expression pattern of NLRP3 and its related cytokines in the lung and brain of avian influenza virus H9N2 infected BALB/c mice
H9N2 avian influenza virus (AIV) becomes the focus for its ability of transmission to mammals and as a donor to provide internal genes to form the new epidemic lethal influenza viruses. Residue 627 in PB2 has been proven the virulence factor of H9N2 avian influenza virus in mice, but the detailed data for inflammation difference between H9N2 virus strains with site 627 mutation is still unclear. The inflammasome NLRP3 is recently reported as the cellular machinery responsible for activation of inflammatory processes and plays an important role during the development of inflammation caused by influenza virus infection. In this study, we investigated the expression pattern of NLRP3 and its related cytokines of IL-1β and TNF-α in BALB/c mice infected by H9N2 AIV strains with only a site 627 difference at both mRNA and protein levels at different time points. The results showed that the expression level of NLRP3, IL-1β and TNF-α changed in the lung and brain of BALB/c mice after infection by VK627 and rVK627E. The immunohistological results showed that the positive cells of NLRP3, IL-1β and TNF-α altered the positive levels of original cells in tissues and infiltrated inflammatory cells which caused by H9N2 infection. Our results provided the basic data at differences in expression pattern of NLRP3 and its related cytokines in BALB/c mice infected by H9N2 influenza viruses with only a site 627 difference. This implied that NLRP3 inflammasome plays a role in host response to influenza virus infection and determines the outcome of clinical manifestation and pathological injury. This will explain the variable of pathological presentation in tissues and enhance research on inflammation process of the AIV H9N2 infection.
- 30 December 2014
- Published by Springer Nature in Virology Journal
- Vol. 11 (1) , 229
Open AccessExpression pattern of NLRP3 and its related cytokines in the lung and brain of avian influenza virus H9N2 infected BALB/c mice
H9N2 avian influenza virus (AIV) becomes the focus for its ability of transmission to mammals and as a donor to provide internal genes to form the new epidemic lethal influenza viruses. Residue 627 in PB2 has been proven the virulence factor of H9N2 avian influenza virus in mice, but the detailed data for inflammation difference between H9N2 virus strains with site 627 mutation is still unclear. The inflammasome NLRP3 is recently reported as the cellular machinery responsible for activation of inflammatory processes and plays an important role during the development of inflammation caused by influenza virus infection. In this study, we investigated the expression pattern of NLRP3 and its related cytokines of IL-1β and TNF-α in BALB/c mice infected by H9N2 AIV strains with only a site 627 difference at both mRNA and protein levels at different time points. The results showed that the expression level of NLRP3, IL-1β and TNF-α changed in the lung and brain of BALB/c mice after infection by VK627 and rVK627E. The immunohistological results showed that the positive cells of NLRP3, IL-1β and TNF-α altered the positive levels of original cells in tissues and infiltrated inflammatory cells which caused by H9N2 infection. Our results provided the basic data at differences in expression pattern of NLRP3 and its related cytokines in BALB/c mice infected by H9N2 influenza viruses with only a site 627 difference. This implied that NLRP3 inflammasome plays a role in host response to influenza virus infection and determines the outcome of clinical manifestation and pathological injury. This will explain the variable of pathological presentation in tissues and enhance research on inflammation process of the AIV H9N2 infection.